| Code | CSB-RA325708MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to SOL-116, targeting carboxylesterase liver (CEL), also known as bile salt-activated lipase (BSAL). CEL is a digestive enzyme primarily expressed in the pancreas and liver that plays a critical role in lipid metabolism by hydrolyzing cholesterol esters, triglycerides, and other lipid substrates in the intestinal lumen. This enzyme is essential for dietary fat absorption and has been implicated in various pathophysiological conditions, including pancreatic disorders, metabolic diseases, and certain malignancies. Mutations in the CEL gene are associated with maturity-onset diabetes of the young (MODY) and chronic pancreatitis, making it a relevant target for investigating digestive and metabolic dysfunction.
As a biosimilar to the reference antibody SOL-116, this reagent provides researchers with a reliable tool for investigating CEL expression, localization, and function in various experimental contexts. It supports studies examining pancreatic enzyme secretion, lipid digestion mechanisms, and the role of CEL in disease pathogenesis, offering valuable insights into digestive physiology and metabolic research.
There are currently no reviews for this product.